RETRACTED: Parkinson's disease-associated melanin steal (Publication with Expression of Concern. See vol. 16, pg. 1063, 2020) (Retracted article. See vol. 17, pg. 733, 2021)

被引:4
作者
Hinz, Marty [1 ]
Stein, Alvin [2 ]
Cole, Ted [3 ]
机构
[1] NeuroRes Clin Inc, Cape Coral, FL 33904 USA
[2] Stein Orthoped Associates, Plantation, FL USA
[3] Cole Ctr Healing, Cincinnati, OH USA
关键词
fluctuations; L-dopa; dopamine; melanocyte; MOTOR FLUCTUATIONS; DNA-DAMAGE; SEROTONIN; DOPAMINE; MANAGEMENT; TYROSINE;
D O I
10.2147/NDT.S74952
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Urinary dopamine fluctuations in the competitive inhibition state were first documented in 2009. At that time, it was noted that progressively higher daily dosing values of L-tyrosine decreased the magnitude of these fluctuations. While extensive statistical analysis has been performed by the authors since 2004, it was not until 2012 that a plausible explanation was formulated. In the process, correlations with L-tyrosine administration and the on/off effect of Parkinson's disease were defined. This paper documents the current knowledge with regard to the management of retrograde phase 1 dopamine fluctuations and investigates the hypothesis that they are caused by a melanin steal phenomenon.
引用
收藏
页码:2331 / 2337
页数:7
相关论文
共 38 条
  • [1] [Anonymous], 2014, TYR MET HOM SAP HUM
  • [2] [Anonymous], PHEN
  • [3] [Anonymous], 2014, SINEMET CARB LEV TAB
  • [4] [Anonymous], UNIPROTKB PYR ORG HO
  • [5] Discrimination between cutaneous pigmentation and erythema: Comparison of the skin colorimeters Dermacatch and Mexameter
    Baquie, M.
    Kasraee, B.
    [J]. SKIN RESEARCH AND TECHNOLOGY, 2014, 20 (02) : 218 - 227
  • [6] Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats
    Borah, Anupom
    Mohanakumar, Kochupurackal P.
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2007, 27 (08) : 985 - 996
  • [7] CHASE TN, 1993, NEUROLOGY, V43, P23
  • [8] Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors
    Daidone, Frederick
    Montioli, Riccardo
    Paiardini, Alessandro
    Cellini, Barbara
    Macchiarulo, Antonio
    Giardina, Giorgio
    Bossa, Francesco
    Voltattorni, Carla Borri
    [J]. PLOS ONE, 2012, 7 (02):
  • [9] de la Fuente-Fernández R, 2001, ANN NEUROL, V49, P298
  • [10] FULLER BB, 1987, J BIOL CHEM, V262, P4024